Goal-Directed Temperature Management During Prolonged Abdominal Surgery
2 other identifiers
interventional
61
1 country
1
Brief Summary
During long operations on the abdomen, patients often get cold. Doctors call this perioperative hypothermia. Even a small drop in body temperature can cause problems, such as more bleeding, wound infection, and a longer stay in hospital. To keep patients warm during surgery, doctors usually blow warm air over the body through a special blanket. However, the fluids that patients receive through a vein during surgery are normally at room temperature. These cool fluids may lower the body temperature from the inside. This study compares two ways of keeping patients warm during operations on the abdomen that last three hours or longer. Everyone taking part receives warm air blown over the body. In addition, one group receives fluids into a vein at room temperature, about 23 °C, which is the usual practice. The other group receives the same fluids warmed to 39 °C by a special device just before the fluid enters the vein. Participants are placed into one of the two groups by chance, like flipping a coin. Because of the nature of the treatment, the doctors caring for the patient know which group the patient is in. The researchers measure body temperature before, during, and at the end of surgery. They also record blood pressure, the medicines used to support blood pressure, the amount of fluid given, the amount of urine produced, and blood tests taken on the day after surgery. This is a pilot study. Its main purpose is to find out whether a larger study would be possible. The researchers want to learn how many patients can be enrolled, whether the treatment can be given exactly as planned, and how complete the collected information is. The results will be used to plan a larger study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2024
CompletedFirst Submitted
Initial submission to the registry
September 25, 2026
CompletedFirst Posted
Study publicly available on registry
October 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 15, 2027
October 2, 2026
October 1, 2026
2.4 years
September 25, 2026
October 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Core body temperature at admission to the intensive care unit
Oesophageal temperature measured at the time of transfer of the participant from the operating room to the intensive care unit, in degrees Celsius.
At transfer to the intensive care unit, up to 12 hours after skin incision
Secondary Outcomes (14)
Perioperative axillary temperature
Before induction of anaesthesia, hourly during surgery, and at admission to the intensive care unit, up to 12 hours
Perioperative oesophageal temperature
Hourly from 1 hour after start of surgery until admission to the intensive care unit, up to 12 hours
Proportion of participants requiring norepinephrine infusion
Intraoperative period, up to 12 hours
Time from skin incision to initiation of norepinephrine infusion
Intraoperative period, up to 12 hours
Norepinephrine infusion rate
Intraoperative period, up to 12 hours
- +9 more secondary outcomes
Other Outcomes (6)
Proportion of screened participants who were randomised
From start of enrolment through study completion, up to 32 months
Proportion of eligible participants who provided informed consent
From start of enrolment through study completion, up to 32 months
Recruitment rate
From start of enrolment through study completion, up to 32 months
- +3 more other outcomes
Study Arms (2)
Control group
ACTIVE COMPARATORForced-air warming applied through an upper body blanket at an airflow temperature of 37 °C from induction of anaesthesia until the end of surgery, combined with intravenous infusion of balanced crystalloid solutions stored at 23 °C and administered without additional warming.
Study group
EXPERIMENTALForced-air warming applied through an upper body blanket at an airflow temperature of 37 °C from induction of anaesthesia until the end of surgery, combined with intravenous infusion of the same balanced crystalloid solutions actively warmed to a target temperature of 39 °C by a medical fluid warmer positioned as close as possible to the venous access site.
Interventions
Forced-air warming system with an upper body blanket; airflow temperature set at 37 °C; applied identically in both groups from induction of anaesthesia until the end of surgery.
Balanced crystalloid solutions actively warmed to a target temperature of 39 °C using a medical fluid warmer; the infusion line is placed inside the heating element as close as possible to the venous access site.
Balanced crystalloid solutions stored at an ambient temperature of 23 °C and administered intravenously without additional warming.
Eligibility Criteria
You may qualify if:
- Signed written informed consent
- Age 18 years or older
- Scheduled abdominal surgery with an expected duration of at least 3 hours
You may not qualify if:
- Pregnancy or breastfeeding
- End-stage chronic somatic disease
- Axillary temperature above 37.0 °C before surgery
- Documented thermoregulatory disorder of any origin, including disorders due to ongoing infectious or autoimmune disease or traumatic brain injury
- Chronic heart failure stage 2 according to the classification of the Russian Society of Cardiology
- Active infection before surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Leningrad Regional Clinical Hospital
Saint Petersburg, 194291, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valentin S Kozlov, MD
The Leningrad Regional Clinical Hospital
- PRINCIPAL INVESTIGATOR
Ionas S Simutis, MD, Dsc
North-Western State Medical University named after I.I.Mechnikov
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiologist, Department of Anesthesiology and Intensive Care
Study Record Dates
First Submitted
September 25, 2026
First Posted
October 2, 2026
Study Start
November 15, 2024
Primary Completion (Estimated)
April 15, 2027
Study Completion (Estimated)
June 15, 2027
Last Updated
October 2, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Beginning 6 months after publication of the main results and ending 3 years thereafter.
- Access Criteria
- Requests should be directed to the corresponding author and will be evaluated on the basis of scientific merit. Data will be shared after approval of a proposal and completion of a data access agreement.
De-identified individual participant data underlying the published results will be made available to qualified researchers upon reasonable request to the corresponding author, following approval of a methodologically sound proposal.